Clinical Trials Insight: 700019946
Phase of Trial: Phase I
Latest Information Update: 29 May 2007
At a glance
- Drugs GRC 6211 (Primary)
- Indications Dental pain; Neuropathic pain; Urinary incontinence
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Glenmark Pharmaceuticals S.A.
- 29 May 2007 Status changed from planning to completed.
- 20 Dec 2006 New trial record.